Proposed Scheme of Amalgamation of Zuventus Healthcare Limited and Emcutix Biopharmaceuticals Limited, wholly owned subsidiaries of the Company with Emcure Pharmaceuticals Limited - Holding ....
The filing
Proposed Scheme of Amalgamation of Zuventus Healthcare Limited and Emcutix Biopharmaceuticals Limited, wholly owned subsidiaries of the Company with Emcure Pharmaceuticals Limited - Holding ....
- Company
- Emcure Pharmaceuticals Ltd · BSE 544210
- Filed
- 12 October 2026, 10:29 IST
- BSE category
- Company Update / Scheme of Arrangement
- Tag
- Scheme of Arrangement · selected
- Source
- Open the filing on BSE →
Why it led
- First Scheme of Arrangement from this company — not seen in the 94 trading days on record
- Mid cap · NIFTY 500
Selected by the ranker from 10 filings that day. Each line above is a component of that score, not a comment on the filing.
How often this tag appears
145 of 89,770 filings in the published window carry Scheme of Arrangement · 0.16%
Around it
Most recent filings from Emcure Pharmaceuticals Ltd
- Award_of_Order_Receipt_of_Order Order / Contract
- Closure of Trading Window Trading Window
- Investor Presentation Investor Presentation
The company
Emcure Pharmaceuticals Ltd
BSE 544210 · NSE EMCURE · ISIN INE168P01015 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
Full figures, price and filing history for Emcure Pharmaceuticals Ltd →